Free Trial

Silence Therapeutics (SLN) Short Interest Ratio & Short Volume

Silence Therapeutics logo
$5.14 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$5.19 +0.05 (+0.95%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Silence Therapeutics Short Interest Data

Silence Therapeutics (SLN) has a short interest of 1.47 million shares. This marks a -9.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.5, indicating that it would take 5.5 days of the average trading volume of 300,936 shares to cover all short positions.

Current Short Interest
1,470,000 shares
Previous Short Interest
1,620,000 shares
Change Vs. Previous Month
-9.26%
Dollar Volume Sold Short
$5.44 million
Short Interest Ratio
5.5 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
29,930,000 shares
Percentage of Shares Shorted
4.91%
Today's Trading Volume
168,428 shares
Average Trading Volume
300,936 shares
Today's Volume Vs. Average
56%
Short Selling Silence Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Silence Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SLN Short Interest Over Time

SLN Days to Cover Over Time

SLN Percentage of Float Shorted Over Time

Silence Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20251,470,000 shares $5.44 million -9.3%N/A5.5 $3.70
4/15/20251,620,000 shares $4.54 million +10.2%5.4%6 $2.80
3/31/20251,470,000 shares $4.15 million +4.3%4.9%5.1 $2.82
3/15/20251,410,000 shares $5.51 million +0.7%4.7%4.4 $3.91
2/28/20251,400,000 shares $6.30 million -2.1%4.7%3.7 $4.50
2/15/20251,430,000 shares $6.92 million +10.0%4.8%2.9 $4.84
1/31/20251,300,000 shares $6.93 million +15.0%N/A2.3 $5.33
1/15/20251,130,000 shares $6.01 million +14.7%N/A2.1 $5.32
12/31/2024985,000 shares $6.78 million +5.6%N/A2 $6.88
12/15/2024932,800 shares $6.02 million +32.8%N/A2 $6.45
11/30/2024702,300 shares $5.56 million +84.1%N/A1.7 $7.92
11/15/2024381,500 shares $4.85 million +8.0%N/A1.2 $12.70
10/31/2024353,300 shares $6.11 million +5.6%N/A2 $17.30
10/15/2024334,600 shares $6.12 million +7.2%N/A1.6 $18.29
9/30/2024312,200 shares $5.68 million +6.1%N/A1.4 $18.18
9/15/2024294,200 shares $5.50 million +15.6%N/A1.3 $18.69
8/31/2024254,600 shares $4.86 million -27.4%N/A1.1 $19.09
8/15/2024350,500 shares $5.88 million -37.5%N/A1.7 $16.77
7/31/2024561,200 shares $11.50 million +0.1%N/A3.1 $20.50
7/15/2024560,700 shares $11.49 million -26.2%N/A3.6 $20.49
6/30/2024759,200 shares $14.42 million +15.3%N/A5.1 $19.00
6/15/2024658,400 shares $12.71 million +9.6%N/A5 $19.30
5/31/2024600,700 shares $12.61 million +3.5%N/A4 $20.99
5/15/2024580,600 shares $12.96 million +95.4%N/A3.1 $22.33
4/30/2024297,200 shares $6.50 million +104.0%N/A1.3 $21.86
4/15/2024145,700 shares $3.01 million -10.1%N/A0.6 $20.66
3/31/2024162,000 shares $3.50 million +74.8%N/A0.7 $21.60
3/15/202492,700 shares $2.12 million +100.7%N/A0.4 $22.84
2/29/202446,200 shares $1.18 million +31.6%N/A0.2 $25.47
2/15/202435,100 shares $768,339.00 -76.9%N/A0.2 $21.89
1/31/2024152,200 shares $3.43 million +6.7%N/A0.9 $22.51
1/15/2024142,700 shares $2.53 million +7.9%N/A1.3 $17.70
12/31/2023132,200 shares $2.30 million +1.0%N/A1.7 $17.37
12/15/2023130,900 shares $2.10 million -7.8%N/A2.3 $16.03
11/30/2023141,900 shares $1.83 million +1.0%N/A3.1 $12.87
11/15/2023140,500 shares $1.32 million +4.1%N/A2 $9.39
10/31/2023135,000 shares $904,500.00 -3.6%N/A2.2 $6.70
10/15/2023140,000 shares $1.09 million +3.1%N/A2.1 $7.76
9/30/2023135,800 shares $1.33 million +5.0%N/A2.1 $9.82
9/15/2023129,400 shares $1.29 million +7.9%N/A1.9 $9.95
Silicon Valley Gold Rush (Ad)

A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.

Gates and Altman are betting big—see why
8/31/2023119,900 shares $1.07 million -4.2%N/A1.3 $8.90
8/15/2023125,100 shares $800,640.00 +24.0%N/A2.2 $6.40
7/31/2023100,900 shares $601,364.00 +41.3%0.4%1.5 $5.96
7/15/202371,400 shares $414,120.00 +349.1%0.3%1 $5.80
6/30/202315,900 shares $87,450.00 +52.9%0.1%0.2 $5.50
6/15/202310,400 shares $63,752.00 +7.2%0.0%0.1 $6.13
5/31/20239,700 shares $51,507.00 -56.7%0.0%0.1 $5.31
5/15/202322,400 shares $131,488.00 -36.7%0.1%0.3 $5.87
4/30/202335,400 shares $237,180.00 +91.4%0.1%0.6 $6.70
4/15/202318,500 shares $114,700.00 +30.3%0.1%0.3 $6.20
3/31/202314,200 shares $88,040.00 +11.8%0.1%0.4 $6.20
3/15/202312,700 shares $116,332.00 -12.4%0.0%0.3 $9.16
2/28/202314,500 shares $169,940.00 -17.1%0.1%0.3 $11.72
2/15/202317,500 shares $226,275.00 -22.2%0.1%0.5 $12.93
1/31/202322,500 shares $292,500.00 -2.6%0.1%0.7 $13.00
1/15/202323,100 shares $328,944.00 -24.3%0.1%0.7 $14.24
12/30/202230,500 shares $465,125.00 -23.9%0.1%0.9 $15.25
12/15/202240,100 shares $571,425.00 +28.9%0.1%1 $14.25
11/30/202231,100 shares $487,648.00 +16.5%0.1%0.7 $15.68
11/15/202226,700 shares $368,193.00 +24.2%0.1%0.6 $13.79
10/31/202221,500 shares $247,680.00 -30.7%0.1%0.4 $11.52
10/15/202231,000 shares $331,700.00 -8.3%0.1%0.5 $10.70
9/30/202233,800 shares $339,014.00 +39.7%0.1%0.6 $10.03
9/15/202224,200 shares $310,728.00 +50.3%0.1%0.4 $12.84
8/31/202216,100 shares $162,771.00 -13.9%0.1%0.3 $10.11
8/15/202218,700 shares $182,512.00 +24.7%0.1%0.4 $9.76
7/31/202215,000 shares $153,000.00 -20.6%0.1%0.4 $10.20
7/15/202218,900 shares $209,979.00 +13.2%0.1%0.6 $11.11
6/30/202216,700 shares $197,895.00 +3.7%0.1%0.6 $11.85
6/15/202216,100 shares $149,730.00 -8.0%0.1%0.7 $9.30
5/31/202217,500 shares $161,525.00 +133.3%0.1%0.9 $9.23
5/15/20227,500 shares $74,250.00 -90.6%0.0%0.3 $9.90
4/30/202279,700 shares $969,152.00 +0.3%0.3%3 $12.16
4/15/202279,500 shares $1.36 million -72.4%0.3%3.1 $17.10
3/31/2022287,500 shares $5.46 million +2,562.0%1.0%11.8 $19.00
3/15/202210,800 shares $178,200.00 +10.2%0.0%0.5 $16.50
2/28/20229,800 shares $179,340.00 -31.0%0.0%0.3 $18.30
2/15/202214,200 shares $313,252.00 +97.2%0.1%0.3 $22.06
1/31/20227,200 shares $151,200.00 +111.8%N/A0.2 $21.00
1/15/20223,400 shares $73,542.00 -40.4%N/A0.1 $21.63
12/31/20215,700 shares $136,173.00 -39.4%N/A0.1 $23.89
12/15/20219,400 shares $218,080.00 +261.5%N/A0.2 $23.20
11/30/20212,600 shares $61,100.00 +73.3%N/A0.1 $23.50
11/15/20211,500 shares $33,596.85 +150.0%N/A0.3 $22.40
10/29/2021600 shares $13,194.00 -53.9%N/A0.4 $21.99
10/15/20211,300 shares $28,366.00 +85.7%N/A0.9 $21.82
9/30/2021700 shares $14,427.00 -30.0%N/A0.4 $20.61
9/15/20211,000 shares $22,030.00 +25.0%N/A0.6 $22.03
8/31/2021800 shares $18,480.08 -69.2%N/A0.5 $23.10
8/13/20212,600 shares $65,468.00 -3.7%N/A2 $25.18
Silicon Valley Gold Rush (Ad)

A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.

Gates and Altman are betting big—see why
7/30/20212,700 shares $69,120.00 -20.6%N/A2.3 $25.60
7/15/20213,400 shares $86,700.00 +54.6%N/A2.4 $25.50
6/30/20212,200 shares $57,562.12 +37.5%N/A1.8 $26.16
6/15/20211,600 shares $45,300.16 -46.7%N/A1.8 $28.31
5/28/20213,000 shares $82,380.00 +66.7%N/A3.3 $27.46
5/14/20211,800 shares $45,702.00 +100.0%N/A2.6 $25.39
4/30/2021900 shares $23,481.00 +12.5%N/A1 $26.09
4/15/2021800 shares $18,504.00 +60.0%N/A0.8 $23.13
3/31/2021500 shares $11,475.00 -66.7%N/A0.5 $22.95
3/15/20211,500 shares $37,170.00 +25.0%N/A1.4 $24.78
2/26/20211,200 shares $31,680.00 No ChangeN/A1 $26.40
2/12/20211,200 shares $30,600.00 -55.6%N/A0.9 $25.50
1/29/20212,700 shares $68,850.00 +42.1%N/A2.5 $25.50
1/15/20211,900 shares $41,800.00 No ChangeN/A1.9 $22.00

SLN Short Interest - Frequently Asked Questions

What is Silence Therapeutics' current short interest?

Short interest is the volume of Silence Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,470,000 shares of SLN short. Learn More on Silence Therapeutics' current short interest.

What is a good short interest ratio for Silence Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLN shares currently have a short interest ratio of 6.0. Learn More on Silence Therapeutics's short interest ratio.

Which institutional investors are shorting Silence Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Silence Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Silence Therapeutics' short interest increasing or decreasing?

Silence Therapeutics saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,470,000 shares, a decrease of 9.3% from the previous total of 1,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Silence Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Silence Therapeutics: Sana Biotechnology, Inc. (31.94%), MeiraGTx Holdings plc (3.01%), SIGA Technologies, Inc. (10.24%), Zevra Therapeutics, Inc. (10.35%), Sage Therapeutics, Inc. (8.48%), Amylyx Pharmaceuticals, Inc. (6.30%), Prothena Co. plc (13.84%), PureTech Health plc (0.04%), ABIVAX Société Anonyme (2.48%), Tourmaline Bio, Inc. (19.89%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Silence Therapeutics stock?

Short selling SLN is an investing strategy that aims to generate trading profit from Silence Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Silence Therapeutics?

A short squeeze for Silence Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLN, which in turn drives the price of the stock up even further.

How often is Silence Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLN, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:SLN) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners